LAM test overall | Total | Microbiological reference standard | Composite reference standard | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sensitivity | Specificity | Sensitivity | Specificity | ||||||||||||
N | % (95 % CI) | p-value | N | % (95 % CI) | p-value | N | % (95 % CI) | p-value | N | % (95 % CI) | p-value | ||||
469 | 24/55 | 44 (30–58) | 393/414 | 95 (92–97) | 36/100 | 36 (27–46) | 360/369 | 98 (95–99) | |||||||
By Department | 469 | ||||||||||||||
Inpatient | 70 | 10/15 | 67 (38–88) | 47/55 | 86 (73–94) | 17/40 | 43 (27–59) | 29/30 | 97 (83–100) | ||||||
Out patient | 399 | 14/40 | 35 (21–52) | 0.035 | 346/359 | 96 (94–98) | 0.001 | 19/60 | 32 (20–45) | 0.269 | 331/339 | 98 (95–99) | 0.74 | ||
By CD4 strata* | 454 | ||||||||||||||
CD4 < 100 | 195 | 14/29 | 48 (29–68) | 148/166 | 89 (83–93) | 24/57 | 42 (29–56) | 130/138 | 94 (89–98) | ||||||
CD4 > = 100 | 259 | 8/24 | 33 (16–55) | 0.272 | 233/235 | 99 (97–100) | <0.001 | 9/39 | 23 (11–39) | 0.054 | 219/220 | 100 (98–100) | 0.002 | ||
By MEWS | 469 | ||||||||||||||
MEWS > 4 | 101 | 20/35 | 57 (39–74) | 54/66 | 82 (70–90) | 29/54 | 54 (40–67) | 44/47 | 94 (83–99) | ||||||
MEWS < = 4 | 368 | 4/20 | 20 (6–44) | 0.008 | 339/348 | 97 (95–99) | <0.001 | 7/46 | 15 (6–29) | <0.001 | 316/322 | 98 (96–99) | 0.061 | ||
By Vital status at 60 days** | 397 | ||||||||||||||
Dead | 52 | 10/14 | 71 (42–92) | 33/38 | 87 (72–96) | 14/29 | 48 (29–68) | 22/23 | 96 (78–100) | ||||||
Alive | 345 | 11/34 | 32 (17–51) | 0.013 | 302/311 | 97 (95–99) | <0.001 | 14/58 | 24 (14–37) | 0.023 | 281/287 | 98 (96–99) | 0.483 |